Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
Top Cited Papers
- 1 December 2011
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 55 (6), 1361-1367
- https://doi.org/10.1016/j.jhep.2011.02.031
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosisHepatology, 2010
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseasesJournal of Hepatology, 2009
- Primary biliary cirrhosisHepatology, 2009
- Prognosis of Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cirrhosis. Results of a 10-Yr Cohort Study Involving 297 PatientsThe American Journal of Gastroenterology, 2006
- Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment.Digestive Diseases and Sciences, 2004
- Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosisHepatology, 1999
- Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosisHepatology, 1999
- Ursodeoxycholic Acid Delays the Onset of Esophageal Varices in Primary Biliary CirrhosisMayo Clinic Proceedings, 1997
- Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosisGastroenterology, 1997
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisThe New England Journal of Medicine, 1991